Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeut... Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. Show more
Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis PR Newswire SAN DIEGO, Sept. 13, 2024...
Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer PR Newswire SAN DIEGO, Sept. 12, 2024 FDA approval marks first and only subcutaneous...
Halozyme to Present at Upcoming Investor Conferences PR Newswire SAN DIEGO, Aug. 28, 2024 SAN DIEGO, Aug. 28, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.66 | -5.81875993641 | 62.9 | 63.5 | 58.71 | 1605563 | 60.71860141 | CS |
4 | -4.01 | -6.33992094862 | 63.25 | 65.5327 | 58.59 | 1276276 | 61.37633092 | CS |
12 | 7.01 | 13.4214053226 | 52.23 | 65.5327 | 50.68 | 1270270 | 57.39575758 | CS |
26 | 19.1 | 47.5834578974 | 40.14 | 65.5327 | 37.73 | 1194734 | 51.159201 | CS |
52 | 19.82 | 50.2790461695 | 39.42 | 65.5327 | 32.83 | 1170474 | 44.37702275 | CS |
156 | 17.68 | 42.5409047161 | 41.56 | 65.5327 | 29.85 | 1156933 | 42.76290841 | CS |
260 | 42.91 | 262.767911819 | 16.33 | 65.5327 | 12.71 | 1233960 | 37.23703088 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.